Related Experiment Video
Updated: May 14, 2026

Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
Genes and epigenetic processes as prospective pain targets
Megan Crow1, Franziska Denk1, Stephen B McMahon1
1Wolfson Centre for Age-Related Diseases, King's College London, London SE1 1UL, UK.
Abstract:
Chronic pain affects approximately one in five adults, resulting in a greatly reduced quality of life and a higher risk of developing co-morbidities such as depression. Available treatments often provide inadequate pain relief, but it is hoped that through deeper understanding of the molecular mechanisms underlying chronic pain states we can discover new and improved therapies. Although genetic research has flourished over the past decade and has identified many key genes in pain processing, the budding field of epigenetics promises to provide new insights and a more dynamic view of pain regulation. This review gives an overview of basic mechanisms and current therapies to treat pain, and discusses the clinical and preclinical evidence for the contribution of genetic and epigenetic factors, with a focus on how this knowledge can affect drug development.
Insights
Chronic pain impacts millions, reducing quality of life. Understanding genetic and epigenetic factors in pain offers hope for developing improved therapies and effective drug development strategies.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Chronic pain affects 1 in 5 adults, diminishing quality of life and increasing risks of depression.
- Current pain treatments are often insufficient, necessitating novel therapeutic approaches.
- Genetic research has identified key pain-processing genes, but epigenetics offers a dynamic regulatory perspective.
Purpose of the Study:
- To review basic pain mechanisms and current therapeutic strategies.
- To discuss genetic and epigenetic factors contributing to chronic pain.
- To explore the impact of this knowledge on drug development.
Main Methods:
- Literature review of clinical and preclinical studies.
- Analysis of genetic and epigenetic mechanisms in pain.
- Examination of current pain management and drug development.
Main Results:
- Chronic pain is a complex condition influenced by genetic and epigenetic modifications.
- Epigenetic factors provide a dynamic layer of regulation in pain states.
- Understanding these factors is crucial for advancing pain therapy.
Conclusions:
- Genetic and epigenetic insights are vital for discovering new chronic pain treatments.
- Targeting epigenetic mechanisms may offer novel therapeutic avenues.
- This knowledge can significantly influence future drug development for pain management.
Related Concept Videos
Analgesia and Pain Management
Pain
Nociception
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
